Research output per year
Research output per year
Personal profile
Research interests
Current emphasis is evaluating the science, medicine and business of biopharmaceutical research and development. Our team is assessing how new medicines are discovered and how this has changed, with an emphasis upon assuring that the activities can be sustained in the future.
Fingerprint
Dive into the research topics where Michael Kinch is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
2020 in review: FDA approvals of new medicines
Kinch, M. S., Kraft, Z. & Schwartz, T., 2021, (Accepted/In press) In: Drug Discovery Today.Research output: Contribution to journal › Short survey › peer-review
-
Sources of innovation for new medicines: questions of sustainability
Kinch, M. S., Kraft, Z. & Schwartz, T., Jan 2021, In: Drug Discovery Today. 26, 1, p. 240-247 8 p.Research output: Contribution to journal › Review article › peer-review
2 Scopus citations -
2019 in review: FDA approvals of new medicines
Kinch, M. S., Kraft, Z. & Schwartz, T., Nov 2020, In: Drug Discovery Today. 25, 11, p. 1923-1929 7 p.Research output: Contribution to journal › Short survey › peer-review
1 Scopus citations -
Expanding roles for academic entrepreneurship in drug discovery
Kinch, M. S., Horn, C., Kraft, Z. & Schwartz, T., Nov 2020, In: Drug Discovery Today. 25, 11, p. 1905-1909 5 p.Research output: Contribution to journal › Short survey › peer-review
1 Scopus citations -
Oh, the Frustration of Antibodies!
Kinch, M. S., Oct 9 2020, In: ACS Pharmacology and Translational Science. 3, 5, p. 1035-1036 2 p.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations